2024 ACMG Annual Clinical Genetics Meeting

Date: March 14, 2024
Time: 10:30am – 12:00pm

• Poster presentation by Kurt D. Christensen, PhD: Enrollment of a Diverse Population into a Trial of Newborn Genomic Sequencing: Preliminary Data from the BabySeq Project (P491)
• Poster presentation by Thomas Minten, PhD (mentored by Dr. Nina Gold): Exploring heterogeneity among gene lists proposed for newborn sequencing (P213)
• Poster presentation by Lauren O’Grady, MS, CGC (mentored by Dr. Nina Gold): Phenotypes of adults with MPS1 pseudodeficiency variants: Questioning the need to report in newborns (P017)
• Poster presentation by Hadley S. Smith, PhD, MPSA: Newborn genomic sequencing for Duchenne muscular dystrophy: Model-based insights (P507)

Time: 4:15pm – 5:45pm

• Nina Gold, MD, FACMG will present, “Using clinical cases to illustrate preconception planning among women with inherited metabolic disorders” as part of the plenary session titled “Body image, contraception, fertility, and beyond: The health of women with genetic disorders”

Time: 5:15 – 5:30pm

• Platform presentation by Jacklyn Omorodion, MD (mentored by Dr. Nina Gold): Low Rate of Hereditary Ovarian Cancer Screening in Individuals Meeting National Comprehensive Cancer Network Guidelines (O29)

Date: March 15, 2024
Time: 10:30am – 12:00pm

• Poster presentation by Hadley S. Smith, PhD, MPSA: Optimism and pessimism about genome sequencing in pediatric health care: Preliminary findings in the BabySeq Project (P858)
• Poster presentation by Ilham Abbasi, BSc (mentored by Dr. Nina Gold): Returning genomic risk for hereditary breast and ovarian cancer: Clinical outcomes through standard of care versus research return of results (P064)